Mohammad Mehdi Gravandi
Overview
Explore the profile of Mohammad Mehdi Gravandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gravandi M, Hosseini S, Alavi S, Noori T, Sureda A, Amirian R, et al.
Iran J Pharm Res
. 2024 Jul;
23(1):e142203.
PMID: 39005733
Alzheimer's disease (AD) is a neurodegenerative condition characterized by progressive cognitive deterioration, including deficits in memory and other cognitive functions. Oxidative stress and free radical damage play significant roles in...
2.
Iranpanah A, Fakhri S, Bahrami G, Majnooni M, Gravandi M, Taghavi S, et al.
J Ethnopharmacol
. 2024 Jan;
323:117708.
PMID: 38181932
Ethnopharmacological Relevance: Fraxinus excelsior L. (FE), commonly known as the ash, belongs to the Oleaceae family and has shown several pharmacological and biological properties, such as antioxidant, immunomodulatory, neuroprotective, and...
3.
Gravandi M, Pourmanouchehri Z, Behbood L, Fakhri S, Mohammadi-Noori E, Zhaleh M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Dec;
397(7):4771-4790.
PMID: 38150015
Rheumatoid arthritis (RA) is the most common chronic inflammatory disease, primarily affecting the joints and with stromal tissue dysregulation causing chronic inflammation and joint destruction. Rutin is a natural flavonoid...
4.
Gravandi M, Abdian S, Tahvilian M, Iranpanah A, Moradi S, Fakhri S, et al.
Phytomedicine
. 2023 Apr;
115:154821.
PMID: 37119761
Background: Multiple dysregulated pathways are behind the pathogenesis of neurodegenerative diseases (NDDs); however, the crucial targets are still unknown. Oxidative stress, apoptosis, autophagy, and inflammation are the most dominant pathways...
5.
Fakhri S, Gravandi M, Abdian S, Moradi S, Echeverria J
Life (Basel)
. 2022 Dec;
12(12).
PMID: 36556325
Spinal cord injury (SCI) possesses a complicated etiology. There is no FDA-approved treatment for SCI, and the majority of current interventions focus on reducing symptoms. During SCI, inflammation, oxidative stress,...
6.
Fakhri S, Gravandi M, Abdian S, Akkol E, Farzaei M, Sobarzo-Sanchez E
Molecules
. 2021 Oct;
26(19).
PMID: 34641529
Neurodegenerative diseases (NDDs) are one of the leading causes of death and disability in humans. From a mechanistic perspective, the complexity of pathophysiological mechanisms contributes to NDDs. Therefore, there is...
7.
Fakhri S, Iranpanah A, Gravandi M, Moradi S, Ranjbari M, Majnooni M, et al.
Phytomedicine
. 2021 Aug;
91:153664.
PMID: 34391082
Background: As common, progressive, and chronic causes of disability and death, neurodegenerative diseases (NDDs) significantly threaten human health, while no effective treatment is available. Given the engagement of multiple dysregulated...
8.
Gravandi M, Fakhri S, Zarneshan S, Yarmohammadi A, Khan H
Metab Brain Dis
. 2021 May;
36(7):1501-1521.
PMID: 33988807
As progressive, chronic, incurable and common reasons for disability and death, neurodegenerative diseases (NDDs) are significant threats to human health. Besides, the increasing prevalence of neuronal gradual degeneration and death...
9.
Javedan K, Hydarpur F, Pour P, Najafi F, Mirzaeei S, Rahimi R, et al.
J Complement Integr Med
. 2021 May;
19(3):743-751.
PMID: 33964194
Objectives: An acquired melanin-related hyperpigmentation that occurs in sun exposure areas is Melasma which presents as gray-brown ridges and macules with prominent margins on the skin. The aim of this...
10.
Majnooni M, Fakhri S, Shokoohinia Y, Kiyani N, Stage K, Mohammadi P, et al.
Front Pharmacol
. 2021 Mar;
11:588467.
PMID: 33658931
Since the outbreak of coronavirus disease 2019 (COVID-19) in December 2019, millions of people have been infected and died worldwide. However, no drug has been approved for the treatment of...